Gpro Webcast And Pwrm.ob Stock Report From Pennytobuck.com
Gen-Probe Incorporated (Nasdaq:GPRO) will present at the Leerink Swann Life Science
Tools and Diagnostics Roundtable Conference on Thursday, August 5, 2010 at approximately 12:50 p.m. Eastern time.
A live webcast of the presention will be scheduled and should be able to be accessed through a link on the investors secontion of www.gen-probe.com. The webcast will be available for 30 days following the event.
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. Gen-Probe has approximately 27 years of expertise in nucleic acid testing (NAT), and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,300 people. For more information, go to www.gen-probe.com.
Power3 Medical Products, Inc. (OTC:PWRM) announced recently that, in collaboration with Lourdes R. Bosquez, MD, it has unexpectedly discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro protein biomarkers in the blood of untreated Alzheimers disease patients compared to patients treated with the widely used anti-dementia drugs Aricept (Donepezil HCl, Pfizer NYSE: PFE), Exelon (Rivastigmine, Novartis NYSE: NVS), and Namenda (Memantine HCl, Forest Laboratories NYSE: FRX). These results relate to the genetically distinct groups of Alzheimers disease patients, i.e., those individuals who possess the Alzheimers high-risk gene for Apolipoprotein E4 and those who do not possess the gene.
Power3 has filed for patent protection for these findings and will be publishing these seminal results in the near future in one of the worlds most prestigious peer-reviewed scientific journals. Power3 also plans to demonstrate the clinical application and benefits of its NuroPro diagnostic tests to healthcare providers located throughout the world. Power3 believes that this will assist the company greatly in an effort to generate sales of its NuroPro diagnostic tests. Power3 is currently working on a joint distribution effort with a number of potential business partners, such as the companies mentioned above, for the sale of its NuroPro diagnostic tests and the development of new drugs.
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB)
by: Bill Pennyman
If You Are Thinking Of Buying Penny Stocks, Here Are A Few Things You Should Know Job And Duties Of Conveyancing Solicitors Weird And Wacky Ways To Stretch Your Dollars A Gift For Chelsea And Marc: 10 Ways To Resolve Inevitable Conflict Is Cb Alive And Well Or Dead And Buried? The Prox Card: What They Are And How They Help How Can A Program That Shows Folder And Directory Size Benefit You? The Best Mens Diving Watch Has All The Features While It Looks Amazing And Awesome No Need To Duck And Cover: Buy The Best Jeans Makereservations For The Low-priced Room And Board Plus Air Tickets To Spend One Of The Pretty Van The Controversy Between The Puritans And The Stage By Thompson What Are The Differences Between Rc Aircraft And Rc Helicopter Rc Helicopters Give You A Wide Sky And Dream